-Collaboration will leverage NeoGenomics’ large oncology diagnostic laboratory and Massive Bio’s proven-at-scale proprietary artificial intelligence platform to accelerate drug discovery and optimize patient selection for clinical trials.
FT. MYERS, FL & NEW YORK, NY, March 22, 2023 – Massive Bio, Inc., a private AI-enabled oncology...
Today we are used to the closure of stores, brands and companies, but now it is the turn of sites that produce quality content site to close. A news I received today made me very sad. DP Review website, which has been serving the...